Allopurinol TreatmenT And oxypurinol Concentrations in gouty patients: Knowing the therapeutic window.

Allopurinol TreatmenT And oxypurinol Concentrations in gouty patients: Knowing the therapeutic window. - ATTACK

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33306

Enrollment

Registered

2009-06-09

Start date

2009-06-09

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aandoening van het bewegingsapparaat gout

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Confirmed gout with urate crystals or tophi 2. First treatment with allopurinol 3. Filled and signed informed consent

Exclusion criteria

Exclusion criteria: 1. Patients younger than 18 years and pregnant women 2. Patients with eGFR

Design outcomes

Primary

Measure	Time frame
- association between oxypurinol concentration and the chance on succesfull treatment of gout (defined as reaching urate concentrations of	—

Secondary

Measure	Time frame
- association between oxypurinol concentration and the risk of getting adverse drug reactions - association between oxypurinol concentration and the chance on succesfull treatment of gout (defined as reaching urate concentrations of	—

Countries

Netherlands

Outcome results